Celularity Inc. Class A Common Stock

CELU XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

31M

Short interest (May 15)

1.3%

Net Short (Jun 03 ): -0.1%

Borrow Fee

3.96%

↓ 38.8%

Available Shares

300K

↑ 24.4%

Price Chart

Company Overview

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001752828

Asset Type: CS

Market Data

Market Cap: $30,682,718

Employees: 115

Status: Active

Short Interest

Current Borrow Fee 3.96%

Range: 3.90% - 3.96%

Available Shares 300K

Range: 70K - 300K

Recent Changes

Fee Change: ↑ 18.6%

Available Change: ↑ 9.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime